News
ONVO
0.3810
-1.30%
-0.0050
Weekly Report: what happened at ONVO last week (0210-0214)?
Weekly Report · 1d ago
Organovo Holdings Delays Quarterly Report Filing
TipRanks · 4d ago
Weekly Report: what happened at ONVO last week (0203-0207)?
Weekly Report · 02/10 10:55
Weekly Report: what happened at ONVO last week (0127-0131)?
Weekly Report · 02/03 10:59
Earnings week ahead: PLTR, AMZN, GOOG, AMD, LLY, PEP, F, PFE, MRK, PYPL and more
Seeking Alpha · 02/02 13:00
Weekly Report: what happened at ONVO last week (0120-0124)?
Weekly Report · 01/27 11:02
Weekly Report: what happened at ONVO last week (0113-0117)?
Weekly Report · 01/20 10:54
Weekly Report: what happened at ONVO last week (0106-0110)?
Weekly Report · 01/13 10:55
Executive reshuffles: META, LUV, CCI and WPM
Seeking Alpha · 01/11 20:54
*Organovo Names Norman Staskey Chief Financial Officer >ONVO
Dow Jones · 01/06 13:07
ORGANOVO ANNOUNCES APPOINTMENT OF NORMAN STASKEY AS CHIEF FINANCIAL OFFICER
Reuters · 01/06 13:05
Press Release: Organovo Announces Appointment of Norman Staskey as Chief Financial Officer
Dow Jones · 01/06 13:05
Weekly Report: what happened at ONVO last week (1230-0103)?
Weekly Report · 01/06 11:02
Organovo Holdings Appoints Norman Staskey as New CFO
TipRanks · 12/31/2024 13:27
Organovo Holdings Appoints Norman Staskey As President, CFO And Principal Financial Officer, Effective December 30, 2024, In Connection With Resignation Of Tomas Hess - Filing
Benzinga · 12/31/2024 13:18
ORGANOVO HOLDINGS INC - TOMAS HESS RESIGNS AS PRESIDENT AND CFO EFFECTIVE DEC 24
Reuters · 12/31/2024 13:06
Weekly Report: what happened at ONVO last week (1223-1227)?
Weekly Report · 12/30/2024 10:57
Weekly Report: what happened at ONVO last week (1216-1220)?
Weekly Report · 12/23/2024 11:03
Weekly Report: what happened at ONVO last week (1209-1213)?
Weekly Report · 12/16/2024 11:04
Weekly Report: what happened at ONVO last week (1202-1206)?
Weekly Report · 12/09/2024 11:02
More
Webull provides a variety of real-time ONVO stock news. You can receive the latest news about Organovo Holding through multiple platforms. This information may help you make smarter investment decisions.
About ONVO
Organovo Holdings, Inc. is a clinical-stage biotechnology company. The Company is focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues, as well as preclinical data. Its segments include research and development (R&D) and Mosaic Cell Sciences (Mosaic). It is also focused on building high fidelity, 3D tissues that recapitulate key aspects of human disease. It uses its proprietary technology to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. Its Mosaic division to serve as a key source of certain primary human cells it utilizes in its research and development efforts. Its 3D human tissue platform is multifaceted. Its NovoGen Bioprinters can also dispense pure hydrogel formulations, provided the physical properties of the hydrogel are compatible with the dispensing parameters.